Clinical trial Recruiting at 5 sites Interventional Ages 14 to 18

Cognitive therapy for youth with social anxiety delivered via video

Official title: The Covideo Study - a Randomized Controlled Trial of Cognitive Therapy for Social Anxiety Disorder in Youth, Comparing Screen to Office Delivery

Run by Sykehuset Innlandet HF · NCT06901128 · Data updated 2026-11-12

This study is testing if video-based cognitive therapy can help young people aged 14-18 with social anxiety feel better compared to traditional in-person therapy.

More Social Anxiety Disorder (SAD) trials

Quick facts

Study typeInterventional
Ages14 Years to 18 Years
SexAll
Enrollment200 (estimated)
SponsorSykehuset Innlandet HF
Academic / other
Locations5 sites (Ottestad, Innlandet and 4 other locations)
StatusRecruiting
StartedApril 1, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2035
Registry record updatedMarch 28, 2025
Trial IDNCT06901128 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are youth aged 14 to 18 years who have been diagnosed with social anxiety disorder and are fluent in Norwegian.

Probably not a fit

Patients with severe depression, acute suicidality, substance abuse issues, psychosis, intellectual disabilities, or significant school absenteeism may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of screen delivery of cognitive therapy for youth aged 14-18 with social anxiety disorder, comparing it to traditional office delivery. The study will assess not only the effectiveness but also the acceptability and sustainability of this approach, while identifying factors that may influence therapy outcomes. Participants will be randomly assigned to either screen or office therapy after an initial screening and diagnostic interview. The trial is conducted across multiple centers in Norway, focusing on improving access to therapy for young people in rural areas.

Why it matters

Potential benefit: If successful, this approach could provide greater access to effective cognitive therapy for youth with social anxiety, potentially improving their mental health and social functioning.

How similar studies have gone: Other studies have shown promise in using technology for delivering therapy, suggesting that this approach may be effective, though this specific method is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Social anxiety disorder primary
* Age 14 to 18 years.
* Norwegian fluency

Exclusion Criteria:

* Severe Depression
* Acute suicidality
* Substance abuse
* Psychosis
* Intellectual Disability
* More than 20% absence from school in previous three months

Where it's running

  • Sykehuset Innlandet, Forskningsavdelingen, Sanderud Sykehus
    Ottestad, Innlandet, Norway
    Recruiting
  • Helse Vest
    Førde, Norway
    Recruiting
  • Helse SørØst
    Hamar, Norway
    Recruiting
  • Helse Nord
    Tromsø, Norway
    Recruiting
  • Helse Midt
    Trondheim, Norway
    Recruiting

Study contacts

  • Principal investigator: Einar R Heiervang, MD PhD — Sykehuset Innlandet HF
  • Study coordinator: Einar R Heiervang, MD PhD
  • Email: einarheiervang@gmail.com
  • Phone: 4799568583

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.